Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2007 1
2008 1
2009 1
2010 2
2011 4
2012 1
2013 2
2014 4
2015 1
2016 1
2018 1
2019 1
2020 1
2021 2
2022 5
2024 5
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Safety and Effectiveness From the Cabotegravir and Rilpivirine Implementation Study in European Locations Study: Phase 3b Hybrid Type III Implementation Study Integrating Cabotegravir + Rilpivirine Long-Acting Into European Clinical Settings.
Jonsson-Oldenbüttel C, Ghosn J, van der Valk M, Florence E, Vera F, De Wit S, Rami A, Bonnet F, Hocqueloux L, Hove K, Ait-Khaled M, DeMoor R, Bontempo G, Latham CL, Gutner CA, Iyer S, Gill M, Czarnogorski M, D'Amico R, van Wyk J. Jonsson-Oldenbüttel C, et al. Among authors: czarnogorski m. J Acquir Immune Defic Syndr. 2024 Aug 15;96(5):472-480. doi: 10.1097/QAI.0000000000003448. Epub 2024 Jul 9. J Acquir Immune Defic Syndr. 2024. PMID: 38985445 Free PMC article. Clinical Trial.
Perspectives of people living with HIV-1 on implementation of long-acting cabotegravir plus rilpivirine in US healthcare settings: results from the CUSTOMIZE hybrid III implementation-effectiveness study.
Garris CP, Czarnogorski M, Dalessandro M, D'Amico R, Nwafor T, Williams W, Merrill D, Wang Y, Stassek L, Wohlfeiler MB, Sinclair GI, Mena LA, Thedinger B, Flamm JA, Benson P, Spreen WR. Garris CP, et al. Among authors: czarnogorski m. J Int AIDS Soc. 2022 Sep;25(9):e26006. doi: 10.1002/jia2.26006. J Int AIDS Soc. 2022. PMID: 36097674 Free PMC article. Clinical Trial.
Operational methods of HIV testing in emergency departments: a systematic review.
Haukoos JS, White DA, Lyons MS, Hopkins E, Calderon Y, Kalish B, Rothman RE; National Emergency Department HIV Testing Consortium. Haukoos JS, et al. Ann Emerg Med. 2011 Jul;58(1 Suppl 1):S96-103. doi: 10.1016/j.annemergmed.2011.03.017. Ann Emerg Med. 2011. PMID: 21684417 Free PMC article. Review.
Nomenclature and definitions for emergency department human immunodeficiency virus (HIV) testing: report from the 2007 conference of the National Emergency Department HIV Testing Consortium.
Lyons MS, Lindsell CJ, Haukoos JS, Almond G, Brown J, Calderon Y, Couture E, Merchant RC, White DA, Rothman RE; National Emergency Department HIV Testing Consortium; Aldridge C, Almond G, Andrade G, Arbelaez C, Archinard TM, Aronin SI, Barrera S, Bateganya M, Bell-Merriam J, Bongiovanni B, Brady K, Branson B, Brosgart C, Brown J, Cadoff E, Calderon Y, Chaille-Arnold L, Cheng B, Chiang W, Copeland B, Cousar RL, Couture E, Czarnogorski M, Delgado K, Erbelding E, Feldman J, Garcia O, Gaydos CA, Glick N, Gripshover B, Haukoos J, Hayes A, Heffelfinger J, Herrera L, Hilley A, Holtgrave D, Hoots B, Hopkins E, Houry D, Howell D, Hsieh YH, Hutchinson AB, Jackson B, Jaker M, Jones K, Jung J, Kampe L, Kan V, Kass N, Kelen GD, Kroc K, Kurth A, Lampe MA, Leider J, Lemanski M, Lindsell CJ, Lyons M, McGovern S, Mercer S, Merchant R, Miertschin N, Miller J, Mitchell P, Nelson S, Onaga L, Paltiel D, Paul S, Pollack H, Raffanti S, Randall L, Rothman R, Sabreen A, Sankoff J, Sasso V, Saylor NB, Schechter E, Schechtman B, Schrantz S, Scribner A, Shahan J, Skiest D, Spielberg F, Stennett IS, Sullivan P, Teahan C, Thompson S, Torres G, Totten V, Wagner K, Walensky R, Waxman M, Weddle A, White D,… See abstract for full author list ➔ Lyons MS, et al. Among authors: czarnogorski m. Acad Emerg Med. 2009 Feb;16(2):168-77. doi: 10.1111/j.1553-2712.2008.00300.x. Epub 2008 Dec 6. Acad Emerg Med. 2009. PMID: 19076107 Free PMC article.
Patient Participant Perspectives on Implementation of Long-Acting Cabotegravir and Rilpivirine: Results From the Cabotegravir and Rilpivirine Implementation Study in European Locations (CARISEL) Study.
Gutner CA, van der Valk M, Portilla J, Jeanmaire E, Belkhir L, Lutz T, DeMoor R, Trehan R, Scherzer J, Pascual-Bernáldez M, Ait-Khaled M, Hernandez B, de Ruiter A, Anand SB, Low EL, Hadi M, Barnes N, Sevdalis N, Mohammed P, Czarnogorski M. Gutner CA, et al. Among authors: czarnogorski m. J Int Assoc Provid AIDS Care. 2024 Jan-Dec;23:23259582241269837. doi: 10.1177/23259582241269837. J Int Assoc Provid AIDS Care. 2024. PMID: 39221544 Free PMC article.
Ageing-resembling phenotype of long-term allogeneic hematopoietic cells recipients compared to their donors.
Czarnogórski MC, Sakowska J, Maziewski M, Zieliński M, Piekarska A, Obuchowski I, Młyński M, Dutka M, Sadowska-Klasa A, Zarzycka E, Bieniaszewska M, Trzonkowski P, Witkowski JM, Hellmann A, Ruckemann-Dziurdzińska K, Zaucha JM. Czarnogórski MC, et al. Immun Ageing. 2022 Nov 2;19(1):51. doi: 10.1186/s12979-022-00308-6. Immun Ageing. 2022. PMID: 36324179 Free PMC article.
Perspectives of healthcare providers on implementation of long-acting cabotegravir plus rilpivirine in US healthcare settings from a Hybrid III Implementation-effectiveness study (CUSTOMIZE).
Czarnogorski M, Garris CP, Dalessandro M, D'Amico R, Nwafor T, Williams W, Merrill D, Wang Y, Stassek L, Wohlfeiler MB, Sinclair GI, Mena LA, Thedinger B, Flamm JA, Benson P, Spreen WR. Czarnogorski M, et al. J Int AIDS Soc. 2022 Sep;25(9):e26003. doi: 10.1002/jia2.26003. J Int AIDS Soc. 2022. PMID: 36094142 Free PMC article. Clinical Trial.
30 results